These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 2109678

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, Greene DA.
    N Engl J Med; 1988 Sep 01; 319(9):548-55. PubMed ID: 3136331
    [Abstract] [Full Text] [Related]

  • 5. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE, Larsen AB, Gregersen G.
    Ugeskr Laeger; 1987 Nov 09; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Can aldose reductase inhibition ameliorate diabetic neuropathy?
    González ER.
    JAMA; 1981 Sep 11; 246(11):1169-70. PubMed ID: 6790734
    [No Abstract] [Full Text] [Related]

  • 8. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
    Christensen JE, Varnek L, Gregersen G.
    Acta Neurol Scand; 1985 Feb 11; 71(2):164-7. PubMed ID: 3920861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current progress in clinical trials of aldose reductase inhibitors in Japan.
    Hotta N, Kakuta H, Ando F, Sakamoto N.
    Exp Eye Res; 1990 Jun 11; 50(6):625-8. PubMed ID: 2115451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical potential of aldose reductase inhibitors in diabetic neuropathy.
    Hamada Y, Nakamura J.
    Treat Endocrinol; 2004 Jun 11; 3(4):245-55. PubMed ID: 16026107
    [Abstract] [Full Text] [Related]

  • 20. Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
    Fagius J, Jameson S.
    J Neurol Neurosurg Psychiatry; 1981 Nov 11; 44(11):991-1001. PubMed ID: 6801211
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.